| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
ADARx Pharmaceuticals, Inc.
13G/A
ADRX · 00654F105
|
9.6% |
11/16/2026
Event 9/30/2026
|
||||
| Zhen Li | 9.6% | |||||
| Zhiqing Zhou | 5.5% | |||||
| Zhen Li and Zhiqing Zhou, as Co-Trustees of the Titanium Boulder Irrevocable Trust dated July 11, 2020 | 5.5% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.